No adverse effect if second dose of different Covid vaccine taken: Govt

But reaching a firm opinion on this will need more scrutiny and understanding, the Centre said

coronavirus, vaccine, vaccination, covid-19
Press Trust of India New Delhi
2 min read Last Updated : May 27 2021 | 8:27 PM IST

Any significant adverse effect is unlikely if the second dose of a different COVID-19 vaccine is administered, but reaching a firm opinion on this will need more scrutiny and understanding, the Centre said on Thursday.

It, however, clarified that both doses administered to an individual should be of the same vaccine as per the existing protocol.

The clarification comes following reports that health workers in Uttar Pradesh's Siddharthnagar district administered Covaxin to 20 villagers who had been given Covishield in the first dose.

NITI Aayog member (Health) V K Paul said the incident needed to be investigated.

"Any significant adverse effect is unlikely if the second dose of a different COVID-19 vaccine is given. In fact, there is a narrative that is going on that taking doses of two different vaccines can lead to stronger immunity... but for a firm opinion, more scrutiny and understanding will be required, he said at a presser.

Commenting on the UP incident, he said, "Even if it has happened, it should not be a cause of concern for the individual, but I urge all health workers to give second dose of the same vaccine.

The incident was reported from the primary health centre in Barhni where people from Audahi Kala and another village received Covaxin shots on May 14.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusCoronavirus TestsCoronavirus Vaccine

First Published: May 27 2021 | 8:25 PM IST

Next Story